Conference Coverage
-
Conference Coverage
Amantadine Hydrochloride Reduces Levodopa-Induced Dyskinesia in Patients With Parkinson’s Disease
PORTLAND, OR—Amantadine hydrochloride extended-release capsules, compared with placebo, result in a statistically significant and clinically...
-
Conference Coverage
Common Genetic Variants Associated With Cognitive Impairment in Parkinson’s Disease
PORTLAND, OR—A large-scale analysis has identified several new putative susceptibility genes that may affect cognitive impairment in Parkinson's...
-
Conference Coverage
How Do Autonomic Symptoms Affect Patients With Early Parkinson’s Disease?
PORTLAND, OR—Autonomic symptoms are present in a majority of patients with early Parkinson’s disease, and symptoms correlate with markers of...
-
Conference Coverage
High-Intensity Exercise May Be Feasible in Patients With Parkinson’s Disease
PORTLAND, OR—High-intensity exercise is feasible and safe in patients with Parkinson’s disease, according to trial results presented at the Fourth...
-
Conference Coverage
Choosing Wisely Initiative Helps Physicians Provide Appropriate Care
HILTON HEAD, SC—Physicians sometimes order unnecessary medical tests and procedures for their patients, which results in wasteful spending and...
-
Conference Coverage
What Are New and Potential Therapies for Neuromuscular Disorders?
HILTON HEAD, SC—Biologics, stem cells, and gene therapy may hold promise as treatments for neuromuscular disorders. Ongoing clinical trials are...
-
Conference Coverage
Asleep Deep Brain Stimulation Placement Offers Advantages in Parkinson’s Disease
PORTLAND, OR—Performing deep brain stimulation (DBS) surgery for Parkinson’s disease using intraoperative CT imaging while the patient is under...
-
Conference Coverage
Neuronal Protein Could Be a Blood Biomarker of MS
LONDON—Higher levels of a neuronal protein were found in the blood of patients with relapsing-remitting multiple sclerosis (RRMS) than in healthy...
-
Conference Coverage
Genetic Variations May Affect Vitamin D Level and MS Relapse Rate
BALTIMORE—A genetic scoring system for identifying individuals at high risk for low vitamin D levels also detects patients with multiple sclerosis...
-
Conference Coverage
Hormonal Contraceptives: Risk or Benefit in Migraine?
SAN DIEGO—Among women with migraine, low-dose combined estrogen–progestin contraceptives do not increase the risk of stroke, and continuous...
-
Conference Coverage
Can a Diabetes Drug Treat Parkinson’s Disease?
PORTLAND, OR—Researchers have completed a double-blinded, placebo-controlled trial examining the potential benefits of a new formulation of...
-
Conference Coverage
Gantenerumab Reduces Levels of Biomarkers Associated With Alzheimer’s Disease
TORONTO—The fully human monoclonal antibody gantenerumab may reduce levels of neurogranin, a postsynaptic degradation marker specific to Alzheimer...
-
Conference Coverage
Lipoic Acid Reduces Brain Atrophy in Secondary Progressive MS
LONDON—Daily oral intake of 1,200 mg of racemic lipoic acid significantly reduces the rate of whole brain atrophy among patients with secondary...
-
Conference Coverage
Polychlorinated Biphenyls Are Associated With Risk of Parkinson’s Disease
PORTLAND, OR—Higher serum levels of polychlorinated biphenyls (PCBs) were associated with an increased risk of Parkinson’s disease in two...
-
Conference Coverage
How Much MS Disease Activity Is Acceptable?
LONDON—No evidence of disease activity (NEDA) is a worthy but potentially problematic goal in the care of patients with multiple sclerosis (MS),...
-
Conference Coverage
Does Transdermal Nicotine Benefit Patients With Parkinson’s Disease?
PORTLAND, OR—High doses of transdermal nicotine failed to improve off motor symptoms in patients with Parkinson’s disease, according to trial...
-
Conference Coverage
Transcranial Direct Current Stimulation Enhances Cognitive Training in Parkinson’s Disease
PORTLAND, OR—Combining transcranial direct current stimulation (tDCS) and cognitive training resulted in an improvement in a greater number of...
-
Conference Coverage
Vitamin D as an Add-On Therapy May Improve MRI Outcomes in MS
LONDON—High-dose vitamin D as an add-on therapy may improve MRI outcomes in patients with relapsing-remitting multiple sclerosis (MS), according...
News Roundup
-
News Roundup
New and Noteworthy Information—November 2016
Exercise may be associated with a small benefit for elderly people who have memory and thinking problems, according to a study published online...
Literature Review
-
Literature Review
Statins Are Underused in Recent-Onset Parkinson’s Disease
Many patients with recent-onset Parkinson’s disease have increased cardiovascular risk, but statin therapy is underused in this population,...
-
Literature Review
Switching Between Generic AEDs Not Linked to Hospital Visits for Seizure
Switching between generic versions of the same antiepileptic drug made by different manufacturers does not appear to change the risk of seizure-...
-
Literature Review
Follow-Up of Infants With Zika Virus Identifies Several Neurologic Impairments
A report on 11 infants in Brazil suggests the term “congenital Zika syndrome” be used to describe the abnormalities associated with Zika virus...
-
Literature Review
Early Administration of Sertraline May Prevent Onset of Depression Following TBI
Sertraline may help to prevent the onset of depressive disorders after a traumatic brain injury (TBI), according to data published online ahead of...
-
Literature Review
Alemtuzumab Reduces Preexisting MS Disability
In addition to slowing disability accumulation, alemtuzumab improves preexisting disability in patients with relapsing-remitting multiple...
Commentary
-
Commentary
COMMENTARY—Study Reaffirms FDA Findings
The study by Dr. Kesselheim and his colleagues is one of several recently aimed at reviewing the overall safety of generic drug switching. The FDA...
Patient Information
-
Patient Information
Tips for Living With Trigeminal Neuralgia
Trigeminal neuralgia is a chronic condition that is characterized by short, severe pains felt suddenly along a nerve in the head. Pain varies,...